ATE259235T1 - Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene - Google Patents

Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene

Info

Publication number
ATE259235T1
ATE259235T1 AT95401729T AT95401729T ATE259235T1 AT E259235 T1 ATE259235 T1 AT E259235T1 AT 95401729 T AT95401729 T AT 95401729T AT 95401729 T AT95401729 T AT 95401729T AT E259235 T1 ATE259235 T1 AT E259235T1
Authority
AT
Austria
Prior art keywords
glycans
induction
active principle
transferrin
host
Prior art date
Application number
AT95401729T
Other languages
English (en)
Inventor
Walter Pierpaoli
Gonzague S Kistler
Original Assignee
Cell Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Eng Ag filed Critical Cell Eng Ag
Application granted granted Critical
Publication of ATE259235T1 publication Critical patent/ATE259235T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95401729T 1995-07-20 1995-07-20 Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene ATE259235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95401729A EP0754459B1 (de) 1995-07-20 1995-07-20 Zubereitung enthaltend Glykane übereinstimmend mit Transferrin Glykaner als aktives Prinzip für die Induktion der Immuntoleranz gegen Antigene

Publications (1)

Publication Number Publication Date
ATE259235T1 true ATE259235T1 (de) 2004-02-15

Family

ID=8221508

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95401729T ATE259235T1 (de) 1995-07-20 1995-07-20 Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene

Country Status (8)

Country Link
US (1) US6299878B1 (de)
EP (1) EP0754459B1 (de)
JP (1) JPH11511186A (de)
AT (1) ATE259235T1 (de)
AU (1) AU715022B2 (de)
CA (1) CA2226879A1 (de)
DE (1) DE69532557T2 (de)
WO (1) WO1997003680A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914132A1 (de) * 1996-06-11 1999-05-12 Cellena Ag Transferrin glycane als euthropisches medikament
CA2781858C (en) * 2000-05-12 2015-03-31 Genzyme Corporation Modulators of tnf-.alpha. signaling
DE10132308A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Kombinationspräparat zur Therapie von immunologischen Erkrankungen
AU2002307776A1 (en) * 2002-04-16 2003-10-27 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
AU2003291134A1 (en) * 2002-11-21 2004-06-18 Genzyme Corporation Use of diamide derivatives for inhibiting chronic tissue transplant rejection
ATE520400T1 (de) * 2002-11-21 2011-09-15 Genzyme Corp Kombination von einem diamidderivat und immunsuppressiva zur unterdrückung der transplantatabstossung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0426924A1 (de) * 1989-11-09 1991-05-15 Cellena (Cell Engineering) A.G. Herstellung von Verbindungen mit Metalltransporteigenschaften zur Erleichterung der Transplantation von gewebeunverträglichem Knochenmark und zur Kontrolle der Immunreaktionen im Empfänger

Also Published As

Publication number Publication date
WO1997003680A1 (en) 1997-02-06
DE69532557T2 (de) 2004-12-23
AU6733896A (en) 1997-02-18
US6299878B1 (en) 2001-10-09
CA2226879A1 (en) 1997-02-06
JPH11511186A (ja) 1999-09-28
EP0754459A1 (de) 1997-01-22
EP0754459B1 (de) 2004-02-11
DE69532557D1 (de) 2004-03-18
AU715022B2 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
Iaquinta et al. Adult stem cells for bone regeneration and repair
Gregory et al. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow
Chen et al. Selenium-doped mesoporous bioactive glass regulates macrophage metabolism and polarization by scavenging ROS and promotes bone regeneration in vivo
Galili Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans
Flores et al. Periodontal ligament cell sheet promotes periodontal regeneration in athymic rats
Oursler et al. Identification of osteoclast-specific monoclonal antibodies.
Katz et al. The role of Langerhans cells in antigen presentation
Enzmann et al. Stem cells as tools in regenerative therapy for retinal degeneration
Galili Avoiding detrimental human immune response against Mammalian extracellular matrix implants
US20210145889A1 (en) Methods, compositions, and implantable elements comprising stem cells
Shi et al. Deproteinized bovine bone matrix induces osteoblast differentiation via macrophage polarization
CA2284079A1 (en) Immunotoxins and methods of inducing immune tolerance
Yang et al. Tooth germ‐like construct transplantation for whole‐tooth regeneration: An in vivo study in the miniature pig
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
Sheikh et al. Alpha-gal-independent dual recognition and activation of xenogeneic endothelial cells and human naive natural killer cells1
James et al. HY peptides modulate transplantation responses to skin allografts
Oliveros Anerillas et al. Three-dimensional osteogenic differentiation of bone marrow mesenchymal stem cells promotes matrix metallopeptidase 13 (MMP13) expression in type I collagen hydrogels
WO1998039034A3 (de) Verwendung von anti-cd44 antikörper enthaltenden präparationen zur behandlung bestimmter tumore und zur unterdrückung von immunreaktionen
ATE259235T1 (de) Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene
Melgar-Lesmes et al. Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment
JPH01502592A (ja) 白血病およびある種の悪性腫瘍の治療方法
Honda et al. Enamel tissue engineering using subcultured enamel organ epithelial cells in combination with dental pulp cells
US8440460B2 (en) Methods for transdifferentiating cells
Iwata et al. Cell sheets for periodontal tissue engineering
EP0790834B1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties